USFDA gives tentative approval for this Hypertension drug

It will be manufactured at the group's formulation facility at SEZ, Ahmedabad

89
USFDA
Picture: Pixabay

Last Updated on May 10, 2022 by The Health Master

Zydus Lifesciences said its subsidiary Zydus Worldwide DMCC has received tentative approval from the US health regulator to market its generic version of Selexipag tablets, used to treat pulmonary arterial hypertension in adults.

The approval by the US Food and Drug Administration (USFDA) is for Selexipag tablets in the strengths of 200 mcg, 400 mcg, 600 mcg, 800 mcg, 1,000 mcg, 1,200 mcg, 1,400 mcg, and 1,600 mcg, the company said in a regulatory filing.

These are the generic equivalent of the reference listed drug Uptravi.

It will be manufactured at the group’s formulation facility at SEZ, Ahmedabad, the company said.

Selexipag is used in adults to treat pulmonary arterial hypertension (PAH) to delay disease progression and reduce the risk of hospitalisation for PAH.

Citing IQVIA MAT March 2022 data, the company said Uptravi tablets had annual sales of USD 551 million in the US.

The group now has 331 approvals and has so far filed over 400 abbreviated new drug applications since the commencement of the filing process in FY2003-04, Zydus said.

USFDA gives tentative nod to Zydus for Selexipag tablets

USFDA gives approval to Lupin Pregabalin capsules

USFDA gives final approval to Aleor Dermaceuticals for Docosanol cream

USFDA gives nod to these companies for Bortezomib for injection

USFDA grants approval for drug to treat spondylitis

USFDA approves this oral heart disease drug

Man gets 10-years rigorous imprisonment for making drugs illegally

USFDA gives tentative nod to Zydus for Selexipag tablets

Govt releases guidelines on Pharma innovation and entrepreneurship for academic institutions

USFDA gives approval to Lupin Pregabalin capsules

Global drug development centre set up for APIs and Formulations

New molecule discovered that can be used for treatment of diabetes

USFDA gives final approval to Aleor Dermaceuticals for Docosanol cream

Pharma Sector: “Act as if every day is an Audit”

USFDA gives nod to these companies for Bortezomib for injection

Latest Notifications regarding Pharmaceuticals

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news

Enter your email address:

Delivered by FeedBurner